then go to people who are at high risk of severe disease and then go to people who work in places like hospitals, grocery stores, pharmacies. a high risk of transmission of the virus. we ll see. they may choose to test the water with one foot at a time. if you think about this for a second. when pfizer did its trial, its phase three trial looking for people over 65 years of age. 20,000 got the placebo. that was a big safety and efficacy platform to stand on. when submitting this vaccine a third dose, basically 306 people that got a third dose. so the safety profile is not quite as robust as you d like, as was for the original. may choose to go more slowly. we ll see. and why did the panel recommend thisbooster and do up see it approved for the wider